Physician profile
Eric M Greber
NPI 1225320906
$211,091.32
in general payments reported to CMS, 2019-2025
16 companies · $29K in 2025
The $29K reported for 2025 was more than what 84% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $585 · 2020: $16K · 2021: $41K · 2022: $67K · 2023: $37K · 2024: $20K · 2025: $29K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $53K · Education: $26K · Travel and Lodging: $5,983 · Food and Beverage: $1,447.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $52,557.50 |
| Education | $25,700.00 |
| Travel and Lodging | $5,982.64 |
| Food and Beverage | $1,447.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $210,002.69 | 2019-2025 | Rosa, Taperloc, Anterior Supine Stem Extractor |
| Stryker Corporation | $483.01 | 2020-2025 | Mako |
| Ferring Pharmaceuticals INC. | $109.24 | 2019-2025 | Euflexxa |
| Horizon Therapeutics Plc | $94.09 | 2019-2021 | |
| Pacira Therapeutics, INC. | $72.04 | 2019 | |
| Amgen INC. | $50.14 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $46.49 | 2020-2023 | Exparel, Iovera, Zilretta |
| Abbvie INC. | $42.91 | 2021-2024 | |
| Depuy Synthes Sales INC. | $42.34 | 2021 | |
| Davol INC. | $26.26 | 2022 | |
| Sanofi-Aventis U.S. LLC | $25.38 | 2019 | |
| Convatec INC. | $25.11 | 2024 | |
| Sanara Medtech INC. | $23.41 | 2024 | Celleraterx |
| Heron Therapeutics, INC. | $22.84 | 2024 | Zynrelef |
| Radius Health, INC. | $13.74 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $11.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Greber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.